GlaxoSmithKline asthma app wins AXA PPP Health Tech & You Award
MyAsthma - a mobile app developed by GlaxoSmithKline was one of six winners at the AXA PPP Health Tech & You Awards. The app helps asthma patients understand their condition as well as how to manage symptoms.
Users of the mobile app are able to track medicine usage and asthma attacks, and use location, weather and air quality data to increase their awareness of patient asthma triggers. GSK’s app is the first approved as a Class 1 medical device and has also been CE marked.
Among other winners at the Health Tech & You Awards included software that gamifies physiotherapy treatments, alongside a collection of clothes that heighten or mute senses to help people with autism.
Gordon Henderson, marketing and innovation director at AXA PPP healthcare, said: “The Awards recognise and celebrate the best in personal health technology innovations to benefit consumers and our members to live and maintain a healthy lifestyle.
“The winners and finalists this year show an emergence of artificial intelligence, interactive wearables, gamification and personal medical testing – health tech that would have seemed very ahead of the time when AXA PPP healthcare founded the Health Tech & You programme in 2014.”
The 2017 award winners were announced at The Design Museum in London - they will displayed as part of a free Health Tech & You exhibition.
The AXA PPP Health Tech & You exhibition showcases the most exciting developments in today’s health tech sector. It celebrates true innovation in the sector and allows visitors and media to see how each of the inventions works from real patient testimonials.